160 related articles for article (PubMed ID: 28356331)
1. DNA Damage Induces a Secretory Program in the Quiescent TME that Fosters Adverse Cancer Phenotypes.
Gomez-Sarosi L; Sun Y; Coleman I; Bianchi-Frias D; Nelson PS
Mol Cancer Res; 2017 Jul; 15(7):842-851. PubMed ID: 28356331
[TBL] [Abstract][Full Text] [Related]
2. DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance.
Huber RM; Lucas JM; Gomez-Sarosi LA; Coleman I; Zhao S; Coleman R; Nelson PS
Oncotarget; 2015 Feb; 6(4):2134-47. PubMed ID: 25575823
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathways: involving microenvironment damage responses in cancer therapy resistance.
Sun Y; Nelson PS
Clin Cancer Res; 2012 Aug; 18(15):4019-25. PubMed ID: 22619305
[TBL] [Abstract][Full Text] [Related]
4. Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF).
Vancauwenberghe E; Noyer L; Derouiche S; Lemonnier L; Gosset P; Sadofsky LR; Mariot P; Warnier M; Bokhobza A; Slomianny C; Mauroy B; Bonnal JL; Dewailly E; Delcourt P; Allart L; Desruelles E; Prevarskaya N; Roudbaraki M
Mol Carcinog; 2017 Aug; 56(8):1851-1867. PubMed ID: 28277613
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironment.
Bohonowych JE; Hance MW; Nolan KD; Defee M; Parsons CH; Isaacs JS
Prostate; 2014 Apr; 74(4):395-407. PubMed ID: 24338924
[TBL] [Abstract][Full Text] [Related]
6. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment.
Sun Y; Zhu D; Chen F; Qian M; Wei H; Chen W; Xu J
Oncogene; 2016 Aug; 35(33):4321-34. PubMed ID: 26751775
[TBL] [Abstract][Full Text] [Related]
7. A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation.
Kerr SC; Morgan MM; Gillette AA; Livingston MK; Lugo-Cintron KM; Favreau PF; Florek L; Johnson BP; Lang JM; Skala MC; Beebe DJ
Integr Biol (Camb); 2020 Oct; 12(10):250-262. PubMed ID: 33034643
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
Debelec-Butuner B; Alapinar C; Varisli L; Erbaykent-Tepedelen B; Hamid SM; Gonen-Korkmaz C; Korkmaz KS
Mol Carcinog; 2014 Feb; 53(2):85-97. PubMed ID: 22911881
[TBL] [Abstract][Full Text] [Related]
9. Quiescence does not affect p53 and stress response by irradiation in human lung fibroblasts.
Dai J; Itahana K; Baskar R
Biochem Biophys Res Commun; 2015 Feb; 458(1):104-9. PubMed ID: 25637534
[TBL] [Abstract][Full Text] [Related]
10. Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines.
Ide H; Lu Y; Yu J; China T; Kumamoto T; Koseki T; Yamaguchi R; Muto S; Horie S
Prostate; 2012 Sep; 72(13):1407-11. PubMed ID: 22290195
[TBL] [Abstract][Full Text] [Related]
11. Autophagy is involved in TGF-β1-induced protective mechanisms and formation of cancer-associated fibroblasts phenotype in tumor microenvironment.
Liu FL; Mo EP; Yang L; Du J; Wang HS; Zhang H; Kurihara H; Xu J; Cai SH
Oncotarget; 2016 Jan; 7(4):4122-41. PubMed ID: 26716641
[TBL] [Abstract][Full Text] [Related]
12. Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer.
Baron VT; Pio R; Jia Z; Mercola D
Br J Cancer; 2015 Feb; 112(4):755-64. PubMed ID: 25633035
[TBL] [Abstract][Full Text] [Related]
13. IL37 dampens the IL1β-induced catabolic status of human OA chondrocytes.
van Geffen EW; van Caam AP; van Beuningen HM; Vitters EL; Schreurs W; van de Loo FA; van Lent PL; Koenders MI; Blaney Davidson EN; van der Kraan PM
Rheumatology (Oxford); 2017 Mar; 56(3):351-361. PubMed ID: 27940589
[TBL] [Abstract][Full Text] [Related]
14. Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation.
Doldi V; Callari M; Giannoni E; D'Aiuto F; Maffezzini M; Valdagni R; Chiarugi P; Gandellini P; Zaffaroni N
Oncotarget; 2015 Oct; 6(31):31441-60. PubMed ID: 26375444
[TBL] [Abstract][Full Text] [Related]
15. Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment.
Moore-Smith LD; Isayeva T; Lee JH; Frost A; Ponnazhagan S
Sci Rep; 2017 Aug; 7(1):8678. PubMed ID: 28819116
[TBL] [Abstract][Full Text] [Related]
16. Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.
Mirzayans R; Andrais B; Kumar P; Murray D
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452953
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer.
Kawata H; Kamiakito T; Nakaya T; Komatsubara M; Komatsu K; Morita T; Nagao Y; Tanaka A
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):219-227. PubMed ID: 27329245
[TBL] [Abstract][Full Text] [Related]
18. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone ability to induce premature senescence in human dental pulp stem cells and human dermal fibroblasts.
Seifrtova M; Havelek R; Soukup T; Filipova A; Mokry J; Rezacova M
J Physiol Pharmacol; 2013 Apr; 64(2):255-66. PubMed ID: 23756401
[TBL] [Abstract][Full Text] [Related]
20. Differential cyclooxygenase-2 transcriptional control in proliferating versus quiescent fibroblasts.
Wu KK
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):175-81. PubMed ID: 17481552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
